Bruce Wendel - Net Worth and Insider Trading

Bruce Wendel Net Worth

The estimated net worth of Bruce Wendel is at least $1,969 dollars as of 2024-06-23. Bruce Wendel is the Director of GT Biopharma Inc and owns about 691 shares of GT Biopharma Inc (GTBP) stock worth over $1,969. Details can be seen in Bruce Wendel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bruce Wendel has not made any transactions after 2020-12-22 and currently still holds the listed stock(s).

Transaction Summary of Bruce Wendel

To

Bruce Wendel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bruce Wendel owns 2 companies in total, including GT Biopharma Inc (GTBP) , and Verastem Inc (VSTM) .

Click here to see the complete history of Bruce Wendel’s form 4 insider trades.

Insider Ownership Summary of Bruce Wendel

Ticker Comapny Transaction Date Type of Owner
GTBP GT Biopharma Inc 2022-07-15 director
VSTM Verastem Inc 2018-12-31 director

Bruce Wendel Latest Holdings Summary

Bruce Wendel currently owns a total of 1 stock. Bruce Wendel owns 691 shares of GT Biopharma Inc (GTBP) as of December 22, 2020, with a value of $1,969.

Latest Holdings of Bruce Wendel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GTBP GT Biopharma Inc 2020-12-22 691 2.85 1,969

Holding Weightings of Bruce Wendel


Bruce Wendel Form 4 Trading Tracker

According to the SEC Form 4 filings, Bruce Wendel has made a total of 1 transactions in GT Biopharma Inc (GTBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GT Biopharma Inc is the acquisition of 10 shares on December 22, 2020, which cost Bruce Wendel around $26,279.

Insider Trading History of Bruce Wendel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bruce Wendel Trading Performance

GuruFocus tracks the stock performance after each of Bruce Wendel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce Wendel is -21.29%. GuruFocus also compares Bruce Wendel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce Wendel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bruce Wendel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bruce Wendel

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.18 LIMIT LIMIT LIMIT LIMIT LIMIT

Bruce Wendel Ownership Network

Ownership Network List of Bruce Wendel

No Data

Ownership Network Relation of Bruce Wendel

Insider Network Chart

Bruce Wendel Owned Company Details

What does GT Biopharma Inc do?

Who are the key executives at GT Biopharma Inc?

Bruce Wendel is the director of GT Biopharma Inc. Other key executives at GT Biopharma Inc include director & Exec. Chair. and Interim CEO Michael Martin Breen , CFO & Secretary Manu Ohri , and Pres. of R&D & CMO Gregory Berk .

GT Biopharma Inc (GTBP) Insider Trades Summary

Over the past 18 months, Bruce Wendel made no insider transaction in GT Biopharma Inc (GTBP). Other recent insider transactions involving GT Biopharma Inc (GTBP) include a net purchase of 50,000 shares made by Michael Martin Breen , and a net purchase of 50,000 shares made by Manu Ohri .

In summary, during the past 3 months, insiders sold 0 shares of GT Biopharma Inc (GTBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GT Biopharma Inc (GTBP) were sold and 3,333 shares were bought by its insiders, resulting in a net purchase of 3,333 shares.

GT Biopharma Inc (GTBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GT Biopharma Inc Insider Transactions

No Available Data

Bruce Wendel Mailing Address

Above is the net worth, insider trading, and ownership report for Bruce Wendel. You might contact Bruce Wendel via mailing address: 70 Eleven O'clock Road, Weston Ct 06883.

Discussions on Bruce Wendel

No discussions yet.